Polypharmacy in neuroleptics side-effects comparison: a bias not to be overlooked

被引：0
|
作者：
Cabral Barata, Pedro [1 ]
机构：
[1] Reg Psykiatrien Vest, Gl Landevej 61, DK-7400 Herning, Denmark
来源：
EARLY INTERVENTION IN PSYCHIATRY | 2022年 / 16卷 / 03期
关键词：
SCHIZOPHRENIA; RISPERIDONE; OLANZAPINE; QUETIAPINE; TRIAL;
D O I：
10.1111/eip.13159
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：323 / 324
页数：2
相关论文
共 50 条
  • [21] Minimizing the non-extrapyramidal side-effects of antipsychotics
    Keks, NA
    ACTA PSYCHIATRICA SCANDINAVICA, 1996, 94 : 18 - 24
  • [22] Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials
    Leucht, S
    Pitschel-Walz, G
    Abraham, D
    Kissling, W
    SCHIZOPHRENIA RESEARCH, 1999, 35 (01) : 51 - 68
  • [23] Side-effects of antiepileptic treatment: the current state of the problem
    Voronkova, K. V.
    Pylaeva, O. A.
    Kholin, A. A.
    Kosyakova, E. S.
    Mazalskaya, O. V.
    Koroleva, N. Yu.
    Akhmedov, T. M.
    Buchneva, I. A.
    Petrukhin, A. S.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2011, 111 (10) : 44 - 51
  • [24] Check the effects: systematic assessment of antipsychotic side-effects in an inpatient cohort
    Hynes, Caroline
    McWilliams, Stephen
    Clarke, Mark
    Fitzgerald, Ita
    Feeney, Larkin
    Taylor, Mark
    Boland, Fiona
    Keating, Dolores
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2020, 10
  • [25] A comparison of the metabolic side-effects of the second-generation antipsychotic drugs risperidone and paliperidone in animal models
    Boyda, Heidi N.
    Procyshyn, Ric M.
    Tse, Lurdes
    Yuen, Jessica W. Y.
    Honer, William G.
    Barr, Alasdair M.
    PLOS ONE, 2021, 16 (01):
  • [26] Symptom response and side-effects of olanzapine and risperidone in young adults with recent onset schizophrenia
    van Bruggen, J
    Tijssen, J
    Dingemans, P
    Gersons, B
    Linszen, D
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2003, 18 (06) : 341 - 346
  • [27] Factors associated with subjective side-effects during clozapine treatment
    Seppala, Niko
    Leinonen, Esa
    Viikki, Merja
    Solismaa, Anssi
    Nuolivirta, Timo
    Kampman, Olli
    NORDIC JOURNAL OF PSYCHIATRY, 2015, 69 (03) : 161 - 166
  • [28] Dysphoric subjective response to neuroleptics in schizophrenia: relationship to extrapyramidal side effects and symptomatology
    Gervin, M
    Browne, S
    Garavan, J
    Roe, M
    Larkin, C
    O'Callaghan, E
    EUROPEAN PSYCHIATRY, 1999, 14 (07) : 405 - 409
  • [29] Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update
    Sriretnakumar, Venuja
    Huang, Eric
    Mueller, Daniel J.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (11) : 1709 - 1731
  • [30] ST2472: a new potential antipsychotic with very low liability to induce side-effects
    Stasi, Maria A.
    Di Serio, Stefano
    Vertechy, Mario
    Schiavone, Antonio
    Ghirardi, Orlando
    Minetti, Patrizia
    Campiani, Giuseppe
    Borsini, Franco
    Carminati, Paolo
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 (03) : 309 - 319
12345